US FDA appoints Scott Colburn as director of device standards
This article was originally published in SRA
The US Food and Drug Administration has appointed Scott Colburn as Director of Standards at its Center for Devices and Radiological Health, effective 1 June1. Mr Colburn has been acting director of standards since October 2011.
You may also be interested in...
Swissmedic will scale back its review procedure for certain anti-infectives if the indications for which approval is being sought are identical to those approved in the EU or the US.
Based on the operational experience gained using the new international standard for reporting suspected adverse reactions in EudraVigilance, the EU has decided to set a date for its mandatory use.
The UK’s Health Research Authority has agreed in principle to implement a new policy that aims to drive a lasting change in clinical trial transparency. Not everyone is convinced.